calendar
10,884 catalysts · 3,603 8k filing · 2,255 grant · 1,189 approval · 1,000 device adverse event · 890 device 510k · 641 device pma
10,884 catalysts · 3,603 8k filing · 2,255 grant · 1,189 approval · 1,000 device adverse event · 890 device 510k · 641 device pma
Failure to Osseointegrate
Adverse Event Without Identified Device or Use Problem
Display or Visual Feedback Problem
Failure to Osseointegrate
Adverse Event Without Identified Device or Use Problem
Loss of Osseointegration
Failure to Osseointegrate
Insufficient Information
Loss of or Failure to Bond; Naturally Worn
Fracture
Adverse Event Without Identified Device or Use Problem
Device Alarm System
Unable to Obtain Readings; Device Displays Incorrect Message
Adverse Event Without Identified Device or Use Problem
Difficult to Fold, Unfold or Collapse; Patient-Device Incompatibility
High Readings
Fracture
Failure to Osseointegrate
Patient Device Interaction Problem
Loss of Osseointegration
Adverse Event Without Identified Device or Use Problem
Material Rupture
Adverse Event Without Identified Device or Use Problem
Material Rupture
Adverse Event Without Identified Device or Use Problem
Loss of Osseointegration
Failure to Read Input Signal
Failure to Read Input Signal
Adverse Event Without Identified Device or Use Problem
Difficult to Advance; Device Dislodged or Dislocated
Fracture
DE grant. $44,984. PI: Prasun K Datta
DK grant. $34,272. PI: Rebekka Hannah Anderson
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: TARO PHARM INDS. Form: TABLET. Route: ORAL
Sponsor: TARO PHARM INDS. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM. Form: TABLET. Route: ORAL
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: AKEBIA. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: AMNEAL. Form: TABLET. Route: ORAL
Sponsor: AMNEAL. Form: TABLET. Route: ORAL
Sponsor: AMNEAL. Form: TABLET. Route: ORAL
Sponsor: AMNEAL. Form: TABLET. Route: ORAL